Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens

BACKGROUND: Miltefosine, an anti-cancer drug that has been successfully repositioned for treatment of Leishmania infections, has recently also shown promising effects against Schistosoma spp targeting all life cycle stages of the parasite. The current study examined the effect of treating Schistosom...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Faham, Marwa H., Eissa, Maha M., Igetei, Joseph E., Amer, Eglal I., Liddell, Susan, El-Azzouni, Mervat Z., Doenhoff, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589257/
https://www.ncbi.nlm.nih.gov/pubmed/28841653
http://dx.doi.org/10.1371/journal.pntd.0005853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589257/
https://www.ncbi.nlm.nih.gov/pubmed/28841653
http://dx.doi.org/10.1371/journal.pntd.0005853

Ejemplares similares